Jef De Brabander - Publications

Affiliations: 
1989-1992 Organic Chemistry Department Ghent University, Ghent, Vlaanderen, Belgium 
 2007- Biochemistry University of Texas Southwestern Medical Center at Dallas, Dallas, TX, United States 

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Yin J, Kang Y, McGrath AP, Chapman K, Sjodt M, Kimura E, Okabe A, Koike T, Miyanohana Y, Shimizu Y, Rallabandi R, Lian P, Bai X, Flinspach M, De Brabander JK, et al. Reply to: The G protein preference of orexin receptors is currently an unresolved issue. Nature Communications. 14: 3163. PMID 37264001 DOI: 10.1038/s41467-023-38765-2  0.672
2022 Povedano JM, Li V, Lake KE, Bai X, Rallabandi R, Kim J, Xie Y, De Brabander JK, McFadden DG. TK216 targets microtubules in Ewing sarcoma cells. Cell Chemical Biology. PMID 35803262 DOI: 10.1016/j.chembiol.2022.06.002  0.684
2022 Yin J, Kang Y, McGrath AP, Chapman K, Sjodt M, Kimura E, Okabe A, Koike T, Miyanohana Y, Shimizu Y, Rallabandi R, Lian P, Bai X, Flinspach M, De Brabander JK, et al. Molecular mechanism of the wake-promoting agent TAK-925. Nature Communications. 13: 2902. PMID 35614071 DOI: 10.1038/s41467-022-30601-3  0.699
2020 Povedano JM, Rallabandi R, Bai X, Ye X, Liou J, Chen H, Kim J, Xie Y, Posner B, Rice L, De Brabander JK, McFadden DG. A Multipronged Approach Establishes Covalent Modification of β-Tubulin as the Mode of Action of Benzamide Anti-cancer Toxins. Journal of Medicinal Chemistry. PMID 33180487 DOI: 10.1021/acs.jmedchem.0c01482  0.684
2012 Wu CY, Feng Y, Cardenas ER, Williams N, Floreancig PE, De Brabander JK, Roth MG. Studies toward the unique pederin family member psymberin: structure-activity relationships, biochemical studies, and genetics identify the mode-of-action of psymberin. Journal of the American Chemical Society. 134: 18998-9003. PMID 23088155 DOI: 10.1021/Ja3057002  0.591
2007 Minna JD, Girard L, Sato M, Peyton M, Lee W, Shames D, Honorio S, Xie Y, Xie X, Lam D, Lockwood W, Lam W, Wang Y, Lam S, Kim E, ... ... De Brabander J, et al. M10-01: Molecular pathogenesis of lung cancer with translation to the clinic Journal of Thoracic Oncology. 2: S178-S179. DOI: 10.1097/01.Jto.0000282957.22684.90  0.563
2004 Li L, Thomas RM, Suzuki H, De Brabander JK, Wang X, Harran PG. A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. Science (New York, N.Y.). 305: 1471-4. PMID 15353805 DOI: 10.1126/Science.1098231  0.621
1998 Wender PA, Martin-Cantalejo Y, Carpenter AJ, Chiu A, De Brabander J, Harran PG, Jimenez JM, Koehler MFT, Lippa B, Morrison JA, Müller SG, Müller SN, Park CM, Shiozaki M, Siedenbiedel C, et al. The chemistry-medicine continuum: Synthetic, computer, spectroscopic and biological studies on new chemotherapeutic leads Pure and Applied Chemistry. 70: 539-546. DOI: 10.1351/Pac199870030539  0.656
1996 De Brabander J, Vandewalle M. Towards the asymmetric synthesis of bryostatin 1 Pure and Applied Chemistry. 68: 715-718.  0.434
Show low-probability matches.